Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 3
1993 1
1994 3
1995 3
1997 3
2001 2
2002 2
2003 1
2005 2
2006 3
2007 2
2008 1
2009 1
2011 1
2013 3
2014 7
2017 3
2018 3
2019 3
2020 6
2021 6
2022 4
2023 3
2024 7
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations.
Ear PH, Marinoni I, Dayton T, Guenter R, Quelle DE, Battistella A, Buishand FO, Chittaranjan S, Nancy Du YC, Marques I, Pellegata NS, Sadowski SM, Tirosh A, April-Monn S, Aurilia C, Jaskula-Sztul R, Baena Moreno MJ, Donati S, English KA, Hernandez Llorens MA, Hodgetts H, Marini F, Martins M, Palmini G, Soldevilla B, Schrader J, Thakker RV, Lines KE. Ear PH, et al. Among authors: quelle de. Endocr Oncol. 2024 Dec 19;4(1):e240055. doi: 10.1530/EO-24-0055. eCollection 2024 Jan 1. Endocr Oncol. 2024. PMID: 39822778 Free PMC article. Review.
Peptide Receptor Radionuclide Therapy and clinical associations with renal and hematological toxicities and survival in patients with neuroendocrine tumors: an analysis from two U.S. medical centers.
Xu T, Dillon JS, Maluccio MA, Quelle DE, Nash SH, Cho H, Limbach KE, Skill NJ, Bren-Mattison Y, O'Rorke MA. Xu T, et al. Among authors: quelle de. J Cancer Res Clin Oncol. 2024 Nov 2;150(11):485. doi: 10.1007/s00432-024-06020-w. J Cancer Res Clin Oncol. 2024. PMID: 39488644 Free PMC article.
The University of Iowa Neuroendocrine Tumor Clinic.
Howe JR, Menda Y, Chandrasekharan C, Bellizzi AM, Quelle DE, O'Dorisio MS, Dillon JS. Howe JR, et al. Among authors: quelle de. Endocr Pract. 2025 Jan;31(1):4-18. doi: 10.1016/j.eprac.2024.09.018. Epub 2024 Sep 28. Endocr Pract. 2025. PMID: 39349242
CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.
Kohlmeyer JL, Lingo JJ, Kaemmer CA, Scherer A, Warrier A, Voigt E, Raygoza Garay JA, McGivney GR, Brockman QR, Tang A, Calizo A, Pollard K, Zhang X, Hirbe AC, Pratilas CA, Leidinger M, Breheny P, Chimenti MS, Sieren JC, Monga V, Tanas MR, Meyerholz DK, Darbro BW, Dodd RD, Quelle DE. Kohlmeyer JL, et al. Among authors: quelle de. Clin Cancer Res. 2023 Sep 1;29(17):3484-3497. doi: 10.1158/1078-0432.CCR-23-0749. Clin Cancer Res. 2023. PMID: 37410426 Free PMC article.
Inhibition of serotonin biosynthesis in neuroendocrine neoplasm suppresses tumor growth in vivo.
Tow DH, Tran CG, Borbon LC, Ridder M, Li G, Kaemmer CA, Abusada E, Mahalingam AH, Sadanandam A, Chandrasekaran C, Dillon J, Spitz DR, Quelle DE, Chan CHF, Bellizzi A, Howe JR, Ear PH. Tow DH, et al. Among authors: quelle de. bioRxiv [Preprint]. 2023 Apr 8:2023.04.07.536013. doi: 10.1101/2023.04.07.536013. bioRxiv. 2023. PMID: 37066322 Free PMC article. Preprint.
71 results